These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2971565)

  • 1. Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease.
    Lloberes P; Ramis L; Montserrat JM; Serra J; Campistol J; Picado C; Agusti-Vidal A
    Eur Respir J; 1988 Jun; 1(6):536-9. PubMed ID: 2971565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence.
    Easton PA; Jadue C; Dhingra S; Anthonisen NR
    N Engl J Med; 1986 Sep; 315(12):735-9. PubMed ID: 2943994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salbutamol and ipratropium bromide solution in the treatment of bronchospasm in asthmatic children.
    Boner AL; De Stefano G; Niero E; Vallone G; Gaburro D
    Ann Allergy; 1987 Jan; 58(1):54-8. PubMed ID: 2948430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease.
    Braun SR; McKenzie WN; Copeland C; Knight L; Ellersieck M
    Arch Intern Med; 1989 Mar; 149(3):544-7. PubMed ID: 2521997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative dose-response curves for assessing combined effects of salbutamol and ipratropium bromide in chronic asthma.
    Grandordy BM; Thomas V; de Lauture D; Marsac J
    Eur Respir J; 1988 Jun; 1(6):531-5. PubMed ID: 2971564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchodilators in patients with chronic obstructive pulmonary disease on mechanical ventilation. Utilization of metered-dose inhalers.
    Fernandez A; Lazaro A; Garcia A; Aragon C; Cerda E
    Am Rev Respir Dis; 1990 Jan; 141(1):164-8. PubMed ID: 2136979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis.
    Leitch AG; Hopkin JM; Ellis DA; Merchant S; McHardy GJ
    Thorax; 1978 Dec; 33(6):711-3. PubMed ID: 154748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study.
    Gross NJ; Petty TL; Friedman M; Skorodin MS; Silvers GW; Donohue JF
    Am Rev Respir Dis; 1989 May; 139(5):1188-91. PubMed ID: 2523681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchodilatation and the site of airway resistance in severe chronic bronchitis.
    Douglas NJ; Davidson I; Sudlow MF; Flenley DC
    Thorax; 1979 Feb; 34(1):51-6. PubMed ID: 155891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].
    Ginesu F; Ortu AR; Schena GP; Deiola G; Polo F
    Arch Monaldi; 1983; 38(5-6):241-54. PubMed ID: 6238579
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical physiological data on the bronchodilator effect of Duovent versus salbutamol in chronic obstructive lung disease.
    Marangio E; Pesci A; Mori A; Marchioni M; Bertorelli G
    Respiration; 1986; 50 Suppl 2():165-8. PubMed ID: 2951798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation.
    Brown IG; Chan CS; Kelly CA; Dent AG; Zimmerman PV
    Thorax; 1984 Apr; 39(4):272-6. PubMed ID: 6232724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximal expiratory flows and forced vital capacity in normal, asthmatic and bronchitic subjects after salbutamol and ipratropium bromide.
    Thiessen B; Pedersen OF
    Respiration; 1982; 43(4):304-16. PubMed ID: 6213991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of aerosols in obstructive respiratory tract diseases. Clinical-pharmacological studies using fenoterol, salbutamol, ipratropium bromide and terbutaline].
    Kaik G
    Schweiz Med Wochenschr; 1977 Dec; 107(52):1948-57. PubMed ID: 145654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of salbutamol and ipratropium in chronic bronchitis and chronic airflow limitation.
    Barnes D; Delaney JC
    Br J Clin Pract; 1988 Sep; 42(9):372-6. PubMed ID: 2978246
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solutions assessing dose-response and duration of action.
    McIntosh D
    Pharmatherapeutica; 1986; 4(7):416-21. PubMed ID: 2938194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solution assessing dose-response and duration of action.
    McIntosh D
    Respiration; 1986; 50 Suppl 2():310-2. PubMed ID: 2951827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of vaporizing high doses of ipratropium bromide on lung ventilation in patients with chronic obstructive pulmonary disease and bronchial asthma].
    Dor A; Krasnowska M; Małolepszy J
    Pneumonol Alergol Pol; 1994; 62(1-2):75-9. PubMed ID: 8075617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dose response study comparing Duovent vs salbutamol.
    Stewart DE; Gillies AJ
    N Z Med J; 1987 Dec; 100(837):742-4. PubMed ID: 2967936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute bronchodilator trials in chronic obstructive pulmonary disease.
    Nisar M; Earis JE; Pearson MG; Calverley PM
    Am Rev Respir Dis; 1992 Sep; 146(3):555-9. PubMed ID: 1387772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.